Modulation of monocyte-endothelial cell interactions by platelet microparticles

Journal of Clinical Investigation

Volumn 102, Issue 1, 1998, Pages 136-144

  Barry, Orla P ^a   Praticò, Domenico ^a   Savani, Rashmin C ^a   FitzGerald, Garret A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adhesion; Arachidonic acid; CD11a; CD11b; ICAM 1

Indexed keywords

ARACHIDONIC ACID; CD11B ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANTIGEN EXPRESSION; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

EID: 0032128299     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2592     Document Type: Article

References (61)

1. Sims, P.J., E.M. Faioni, T. Wiedmer, and S.J. Shattil. 1988. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J. Biol. Chem. 263:18205-18212.
2. Sims, P.J., T. Wiedmer, C.T. Esmon, H.J. Weiss, and S.J. Shattil. 1989. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J. Biol. Chem. 264:17049-17057.
3. Satta, N., F. Toti, O. Feugeas, A. Bohbot, J. Dachary-Prigent, V. Eschwege, H. Hedman, and J.H. Freyssinet. 1994. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J. Immunol. 153:3245-3255.
4. Molino, M., D.F. Bainton, J.A. Hoxie, S.R. Coughlin, and L.F. Brass. 1997. Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation. J. Biol. Chem. 272:6011-6017.
5. Satta, N., J.M. Freyssinet, and F. Toti. 1997. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. Br. J. Haematol. 96:534-542.
6. Tans, G., J. Rosing, M.C. Thomassen, M.J. Heeb, R.F. Zwaal, and J.H. Griffin. 1991. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles Blood. 77:2641-2648.
7. Iwamoto, S., T. Kawasaki, J. Kambayashi, H. Ariyoshi, and M. Monden. 1996. Platelet microparticles: a carrier of platelet-activating factor? Biochem. Biophys. Res. Commun. 218:940-944.
8. Leeuwenberg, J.F., E.F. Smeets, J.J. Neefjies, M.A. Shaffer, T. Cinek. T.M. Jeunhomme, T.J. Ahern, and W.A. Buurman. 1992. E-selectin and intracellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology. 77:543-549.
9. Barry, O.P., D. Praticò, J.A. Lawson, and G.A. FitzGerald. 1997. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J. Clin. Invest. 99:2118-2127.
10. Wilentz, J.R., T.A. Sanborn, C.C. Haudenschild, C.R. Valeri, T.J. Ryan, and D.P. Faxon. 1987. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation. 75:636-642.
11. Numano, F., Y. Kishi, K., Simokado, F. Numano, and M. Yagima. 1990. Antiplatelet therapy for atherosclerotic disorders. Ann. N.Y. Acad. Sci. 598: 356-367.
12. Kaplan, D.R., F.C. Chao, C.D. Stiles, N.H. Antoniades, and C.D. Scher. 1979. Platelet alpha granules contain a growth factor for fibroblasts. Blood. 53: 1043-1052.
13. Claesoon-Welsh, L. 1994. Platelet-derived growth factor receptor signals. J. Biol. Chem. 269:32023-32026.
14. Schwartz, L., M.G. Bourassa, J. Lespérance, H.E. Aldridge, F. Kazim, V.A. Salvatori, M. Henderson, R. Bonan, and P.R. David. 1988. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N. Engl. J. Med. 318:1714-1719.
15. 2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT). Circulation. 84:1568-1580.
16. van de Werf, F. 1997. Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes. Thromb. Haemostasis. 78:210-213.
17. Willerson, J.T., J.M. McNatt, F.J. Clubb, N. Nicholson, M.P. Herman, J.J. Ferguson, and P. Zoldhelyi. 1997. Xemilofibran, an oral GPIIb/IIIa receptor antagonist is enhanced by aspirin in inhibiting neointimal proliferation following percutaneous coronary angioplasty. Circulation. 96:930a (Abstr.)
18. Topol, E.J., R.M. Califf, H.F. Weisman, S.G. Ellis, J.E. Tcheng, S. Worley, R. Ivanhoe, B.S. George, D. Fintel, H. Weston et al. 1994. Randomized trial of coronary interaction with antibodies against platelet GpIIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC investigation. Lancet. 343:1434-1435.
19. Ross, R. 1985. Platelets, platelet-derived growth factor, growth control, and their interactions with the vascular wall. J. Cardiovasc. Pharmacol. (Suppl. 7) 3:S186-S190.
20. Wissler, R. W. 1991. Update on the pathogenesis of atherosclerosis. Am. J. Med. 91:35-95.
21. Cookson, F.B. 1971. The origin of foam cells in atherosclerosis. Br. J. Exp. Pathol. 52:62-69.
22. Gerrity, R.G., and H.K. Naito. 1980. Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. Artery. 8:208-214.
23. Boudoulas, H. 1994. Factors determining and prevention of atherosclerotic plaque rupture. Postgrad. Med. J. 70:1:S43-S45.
24. Reilly, I.A., J.B. Doran, B. Smith, and G.A. FitzGerald. 1986. Increased thromboxane biosynthesis in a human model of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. Circulation. 73:1300-1309.
25. Nomura, S., M. Suzuki, K. Katsura, G.L. Xie, Y. Miyazaki, T. Miyake, H. Kido, T. Kagawa, and S. Fukahara. 1995. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis. 116:235-240.
26. Kelton, J.G., T.E. Warkentin, C.P.M. Hayward. W.G. Murphy, and J.C. Moore. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood. 80:2246-2251.
27. Davies, P.F., and S.C. Tripathi. 1993. Mechanical stress mechanisms and the cell. An endothelial paradigm. Circ. Res. 72:239-245.
28. Goyert, S.M., E. Ferrero, W.J. Rettig, A.K. Yeramandra, F. Obata, and M.M. Le Beau. 1988. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science. 239:497-500.
29. FitzGerald, G.A., J.A. Oates, J. Hawiger, R.L. Maas, L.J. Roberts, and A.R. Brash. 1983. Endogenous synthesis of prostacyclin and thromboxane and platelet function during chronic aspirin administration in man. J. Clin. Invest. 71:676-688.
30. Bligh, E.G., and W.J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
31. Jaffe, E.A., R.L. Nachman, C.G. Becker, and C.R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphological and immunological criteria. J. Clin. Invest. 52:2745-2756.
32. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand. J. Clin. Lab. Invest. 97:77-89.
33. Koski, I.R., D.G. Poplack, and R.M. Blaese. 1976. A nonspecific esterase stain for the identification of monocytes and macrophages. In In Vitro Methods in Cell-mediated and Tumor Immunity. B.R. Bloom and J.R. David, editors. Academic Press, New York. 377-386.
34. Gamble, J.R., and M.A. Vadas. 1988. A new assay for the measurement of the attachment of neutrophils and other cell types to endothelial cells. J. Immunol. Methods. 109:175-184.
35. Yufang, S., B.S. Kornovski, R. Savani, and E.A. Turley. 1993. A rapid, multiwell colometric assay for chemotaxis. J. Immunol. Methods. 164:149-154.
36. Carlos, T.M., A. Dobrina, R. Ross, and J.A. Harlan. 1990. Multiple receptors on human monocytes are involved in adhesion to cultured human endothelial cells. J. Leukocyte Biol. 48:451-456.
37. Cavender, D.E., D. Edelbaum, and L. Welkovich. 1991. Effects of inflammatory cytokines and phorbol esters on the adhesion of U-937 cells, a human monocyte-like cell line, to endothelial cell monolayers and extracellular matrix proteins. J. Leukocyte Biol. 49:556-578.
38. Sudstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. 17:565-577.
39. Fischer, D.G., M.C. Pike, H.S. Koren, and R. Snyderman. 1980. Chemolactically responsive and nonresponsive forms of a continuous human monocytic cell line. J. Immunol. 125:463-165.
40. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771-15781.
41. Ginsberg, M.H., X. Du, and E.F. Plow. 1992. Inside-out integrin signaling. Curr. Opin. Cell Biol. 4:766-771.
42. Springer, T.A. 1990. Adhesion receptors in the immune system. Nature. 346:425-434.
43. Derman, M.P., A. Toker, J.H. Hartwig, K. Spokes, J.R. Falck, C.S. Chen, L.C. Cantley, and L.G. Cantley. 1997. The lipid products of phosphoinositide 3-kinase increase cell motility through protein kinase C. J. Biol. Chem. 272:6465-6470.
44. Olivier, A.R., and P.J. Parker. 1992. Identification of multiple PKC isoforms in Swiss 3T3 cells: differential down-regulation of phorbol ester. J. Cell Physiol. 152:240-244.
45. Mantovani, A., and E. Dejana. 1989. Cytokines as communication signals between leukocytes and endothetial cells. Immunol. Today. 10:370-375.
46. Issekutz, T.B., A.C. Issekutz, and H.Z. Movat. 1981. The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissue. Am. J. Pathol. 103:47-55.
47. Bevilacqua, M.P., R.M. Nelson, G. Mannori, and O. Cecconi. 1994. Endothelial-leukocyte adhesion molecules in human disease. Ann. Rev. Med. 45: 361-378.
48. Zimmerman, G.A., T.M. McIntyre, and S.M. Prescott. 1996. Adhesion and signaling in vascular cell-cell interactions. J. Clin. Invest. 98:1699-1702.
49. Davies, P.F., K.A. Barbee, R. Lai, A. Robotewskyi, and M.L. Griem. 1995. Hemodynamics and atherogenesis. Endothelial surface dynamics in flow signal transduction. Proc. Natl. Acad. Sci. USA. 748:86-102.
50. Davies, P.F., K.A. Barbee, M.V. Volin, A. Robotewshyj, J. Chen, L. Joseph, M.L. Griem, M.N. Wernick, E. Jacobs, D.C. Polacek, N. dePaola, and A.I. Barakat. 1997. Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Annu. Rev. Physiol. 59:527-549.
51. Nomura, S., Y. Komiyama, T. Miyake, Y. Miyazaki, H. Kido, M. Suzuki, H. Kagawa, M. Yanabu, H. Takahashi, and S. Fukuhara. 1994. Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease. Thromb. Haemostasis. 72:519-522.
52. Lee, Y.J., W. Jy, L.L. Horstman, J. Janania, Y. Reves, R.E. Kelley, and Y.S. Ahn. 1994. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb. Res. 72:295-304.
53. Holme, P.A., U. Orrim, M.J. Hamers, N.O. Solum, F.R. Brosstad, R.M. Barstad, and K.S. Sakariassen. 1997. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Atheroscler. Thromb. Vasc. Biol. 17:646-653.
54. Beekhuizen, H., I. Blokland, and R. vanFurth. 1993. Cross-linking of CD14 molecules on monocytes results in a CD11/CD18-and ICAM-1-dependent adherence to cytokine-stimulated human endothelial cells. J. Immunol. 150:950-959.
55. Pober, J.S., M.A. Gimbrone, L.A. Lapierre, D.L. Mendrick, W. Fiers, R. Rothlein, and T.A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1893-1896.
56. Dustin, M.L., and T.A. Springer. 1988. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J. Biol. Chem. 107:321-331.
57. Diamond, M.S., D.E. Staunton, A.R. de Fougerolles, S.A. Stacker, J. Garcia-Aguilar, M.L. Hibbs, and T.A. Springer. 1990. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J. Cell Biol. 111:3129-3139.
58. Lo, S.K., G.A. Van Seventer, S.M. Levin, and S.D. Wright. 1989. Two leukocyte receptors (CD11a/CD18 and CD11b/CD18) mediate transient adhesion to endothelium by binding to different ligands. J. Immunol. 143:3325-3329.
59. Beekhuizen, H., A.J. Corsel-Van Tilburg, I. Blokland, and R. Van Furth. 1991. Characterization of the adherence of human monocytes to cytokine-stimulated human macrovascular endothelial cells. Immunology. 74:661-669.
60. Rice, G.E., J.M. Munro, and M.P. Bevilacqua. 1990. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism. J. Exp. Med. 171:1369-1374.
61. Renkonen, R. 1990. Activation of protein kinases A and C increases lymphocyte penetration through endothelial monolayers. FEBS Lett. 267:89-92.